4
Changes in Ownership
Kalaris Therapeutics, Inc. Filed Acc 0001209191-23-004500
Chief Accounting Officer sold 1,895 shares at an average $5.09 ($9,645)
From the SEC's structured data for this filing
Trades in this filing
Hagen Brett R · Chief Accounting Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-01-19 | Sale : show line 1 in the form | −1,557 | $5.08 | $7,906 | 74,342 | D |
| 2023-01-20 | Sale : show line 2 in the form | −338 | $5.14 | $1,739 | 74,004 | D |
| Open-market sales · 1,895 sh · avg $5.09 · $9,645 | ||||||
Loading xslF345X03/doc4.xml…